S 1097
Interagency Patent Coordination and Improvement Act of 2025
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill establishes an Interagency Task Force between the United States Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) to improve coordination and information sharing regarding patents for human drugs and biological products. The task force will facilitate the exchange of information between the agencies, including details about patent applications, FDA approvals, and relevant scientific data. It also requires the USPTO to request information from the FDA to assist patent examiners and the FDA to provide that information, while ensuring the USPTO assists the FDA in its patent listing duties.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Thomas Tillis
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.